| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pediatric Neurology, Hacettepe University, Ankara, Turkey.
We treated 22 patients with subacute sclerosing panencephalitis (SSPE) with intraventricular 
-interferon (IFN) and inosiplex PO and followed them for 2 to 54 months. Three deaths occurred. Clinical improvement, demonstrated by decreasing scores on the Neurological Disability Index, occurred in 11/22 (50%); five patients became stable, and the progression rate of the disease decreased in three. The remission rate was significantly higher than untreated controls from the same institution. Patients who had a slowly progressive disease responded best to treatment. Serious side effects were rare. We recommend intraventricular IFN, combined with oral inosiplex, in the treatment of SSPE.
Address correspondence and reprint requests to Dr. B. Anlar, Department of Pediatric Neurology, Hacettepe University, Ankara, Turkey.
Received September 18, 1991. Accepted for publication in final form November 22, 1991.
This article has been cited by other articles:
|
|
 |
|
  A. J. Cole, J. W. Henson, M. H.A. Roehrl, and M. P. Frosch Case 24-2007 -- A 20-Year-Old Pregnant Woman with Altered Mental Status N. Engl. J. Med., August 9, 2007; 357(6): 589 - 600. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Yilmaz, H. Caksen, N. Yilmaz, A. S. Guven, and I. Bayram Two Cases of Subacute Sclerosing panencephalitis Associated with Brainstem Involvement J Trop Pediatr, August 1, 2007; 53(4): 280 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.K. Prashanth, A.B. Taly, S. Sinha, and V. Ravi Subacute Sclerosing Panencephalitis (SSPE): An Insight Into the Diagnostic Errors From a Tertiary Care University Hospital J Child Neurol, June 1, 2007; 22(6): 683 - 688. [Abstract] [PDF]
|
|
|
|
|
|
S. Gungor, A. Olmez, Pinar Arikan Firat, G. Haliloglu, and B. Anlar Serum Retinol and {beta}-Carotene Levels in Subacute Sclerosing Panencephalitis J Child Neurol, March 1, 2007; 22(3): 341 - 343. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Kurata, E. Matsubara, M. Yokoyama, I. Nagano, M. Shoji, and K. Abe Improvement of SSPE by intrathecal infusion of {alpha}-IFN Neurology, July 27, 2004; 63(2): 398 - 399. [Full Text] [PDF]
|
|
|
|
|
|
O. F. Aydin, N. Senbil, and Y. K. Y. Gurer Response to Dr Anlar J Child Neurol, June 1, 2004; 19(6): 463 - 464. [PDF]
|
|
|
|
|
|
G. G. Gascon Randomized Treatment Study of Inosiplex Versus Combined Inosiplex and Intraventricular Interferon-{alpha} in Subacute Sclerosing Panencephalitis (SSPE): International Multicenter Study J Child Neurol, December 1, 2003; 18(12): 819 - 827. [Abstract] [PDF]
|
|
|
|
|
|
O. F. Aydin, N. Senbil, N. Kuyucu, and Y.K. Y. Gurer Combined Treatment With Subcutaneous Interferon-{alpha}, Oral Isoprinosine, and Lamivudine for Subacute Sclerosing Panencephalitis J Child Neurol, February 1, 2003; 18(2): 104 - 108. [Abstract] [PDF]
|
|
|
|
|
|
T. Solomon, C. A. Hart, S. Vinjamuri, N. J. Beeching, C. Malucci, and P. Humphrey Treatment of Subacute Sclerosing Panencephalitis With Interferon-{alpha}, Ribavirin, and Inosiplex J Child Neurol, September 1, 2002; 17(9): 703 - 705. [Abstract] [PDF]
|
|
|
|
|
|
A. Ozturk, C. Gurses, B. Baykan, A. Gokyigit, and M. Eraksoy Subacute Sclerosing Panencephalitis: Clinical and Magnetic Resonance Imaging Evaluation of 36 Patients J Child Neurol, January 1, 2002; 17(1): 25 - 29. [Abstract] [PDF]
|
|
|
|
|
|
B. Anlar, F. Soylemezoglu, S. Aysun, G. Kose, D. Belen, and K. Yalaz Tissue Inflammatory Response in Subacute Sclerosing Panencephalitis (SSPE) J Child Neurol, December 1, 2001; 16(12): 895 - 900. [Abstract] [PDF]
|
|
|
|
|
|
S. Haspolat, B. Anlar, G. Kose, M. Coskun, and O. Yegin Interleukin-1{beta}, Interleukin-1 Receptor Antagonist Levels in Patients With Subacute Sclerosing Panencephalitis and the Effects of Different Treatment Protocols J Child Neurol, June 1, 2001; 16(6): 417 - 420. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Y. Park and S. Kohl Subacute Sclerosing Panencephalitis in an Identical Twin Pediatrics, December 1, 1999; 104(6): 1390 - 1394. [Full Text]
|
|
|
|
|
|
H. Tekgul, S. Tutuncuoglu, N. Kutukculer, G. Dizdarer, and A. Huseyinov Lymphocyte Subsets and Inflammatory Mediators in Patients With Subacute Sclerosing Panencephalitis J Child Neurol, July 1, 1999; 14(7): 418 - 421. [Abstract] [PDF]
|
|
|
|
|
|
B. Anlar, K. Yalaz, G. Kose, and S. Saygi {beta}-Interferon Plus Inosiplex in the Treatment of Subacute Sclerosing Panencephalitis J Child Neurol, November 1, 1998; 13(11): 557 - 559. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Mrkic, J. Pavlovic, T. Rulicke, P. Volpe, C. J. Buchholz, D. Hourcade, J. P. Atkinson, A. Aguzzi, and R. Cattaneo Measles Virus Spread and Pathogenesis in Genetically Modified Mice J. Virol., September 1, 1998; 72(9): 7420 - 7427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Gascon Treatment of Subacute Sclerosing Panencephalitis J Child Neurol, November 1, 1997; 12(8): 469 - 470. [PDF]
|
|
|
|
|
|
M. N. Fayad, B. I. Yamout, and S. Mroueh Alpha-Interferon in the Treatment of Subacute Sclerosing Panencephalitis J Child Neurol, November 1, 1997; 12(8): 486 - 488. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Nester Use of a Brief Assessment Examination in a Study of Subacute Sclerosing Panencephalitis J Child Neurol, May 1, 1996; 11(3): 173 - 180. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
